Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1603PDF: 949HTML: 1023figures: 226table 1: 226table2: 228table3: 228 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4962PDF: 1878HTML: 2871Untitled: 270 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4509Suppl. Files: 1236PDF: 1147Html: 301 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3471PDF: 1315HTML: 8398 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
906PDF: 513HTML: 1316 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
1040PDF: 563HTML: 747 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3842PDF: 1330HTML: 3936Untitled: 279Untitled: 308 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3891PDF: 1671HTML: 871Figures . Eliassian: 273 -
IMMUNOLOGY OF TUBERCULOSIS
5839PDF: 2210HTML: 7366Untitled: 238 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10943PDF: 6554HTML: 21962 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1044PDF: 601HTML: 2228Cover Letter: 229 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3590PDF: 1450HTML: 2726 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2699PDF: 1237HTML: 286 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1500PDF: 874HTML: 3144 -
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4649PDF: 1803HTML: 1284 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1292PDF: 638HTML: 6934 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1547PDF: 1386HTML: 120 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3549PDF: 1395HTML: 6350 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3194PDF: 1072HTML: 3207 -
-
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1654PDF: 1084HTML: 146 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7428PDF: 4106HTML: 24982







